LCN Stock Overview
Engages in the cultivation, production, and distribution of hemp product. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Labocanna S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.37 |
| 52 Week High | zł0.67 |
| 52 Week Low | zł0.26 |
| Beta | 2.98 |
| 1 Month Change | 12.84% |
| 3 Month Change | 2.50% |
| 1 Year Change | -31.67% |
| 3 Year Change | -83.07% |
| 5 Year Change | n/a |
| Change since IPO | -72.87% |
Recent News & Updates
Shareholder Returns
| LCN | PL Pharmaceuticals | PL Market | |
|---|---|---|---|
| 7D | 14.6% | 0.6% | 4.7% |
| 1Y | -31.7% | 24.0% | 9.1% |
Return vs Industry: LCN underperformed the Polish Pharmaceuticals industry which returned 24% over the past year.
Return vs Market: LCN underperformed the Polish Market which returned 9.1% over the past year.
Price Volatility
| LCN volatility | |
|---|---|
| LCN Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in PL Market | 10.0% |
| 10% least volatile stocks in PL Market | 3.5% |
Stable Share Price: LCN's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: LCN's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 3 | Pawel Kicinski | labocanna.pl |
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD hemp oil under the Labocanna brand name. Its products are used in cosmetics, plastics, and textiles.
Labocanna S.A. Fundamentals Summary
| LCN fundamental statistics | |
|---|---|
| Market cap | zł7.82m |
| Earnings (TTM) | -zł309.36k |
| Revenue (TTM) | zł2.50k |
3,129x
P/S Ratio-25.3x
P/E RatioIs LCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LCN income statement (TTM) | |
|---|---|
| Revenue | zł2.50k |
| Cost of Revenue | zł117.59k |
| Gross Profit | -zł115.09k |
| Other Expenses | zł194.27k |
| Earnings | -zł309.36k |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.015 |
| Gross Margin | -4,603.68% |
| Net Profit Margin | -12,374.28% |
| Debt/Equity Ratio | 0% |
How did LCN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/12 21:59 |
| End of Day Share Price | 2025/02/12 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Labocanna S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.